Latest steps forwards EnviGuard chemicals module
Source : enviguard.net
BIOTEM, has successfully developed high affinity and specific monoclonal antibodies against PCBs (PCB169 & PCB 126) and Okadaic Acid. Thanks…
Read the full article at http://www.enviguard.net/index.php/news/item/13-advances-enviguard-chemicals-module
Héloïse BRUNETON posted an update in the hub Open Innovation and Technology Transfer Publications Feed 7 hours, 30 minutes ago
Open Innovation in the Life Sciences | Biowebspin
To date, the open innovation approach has been implemented successfully in the chemicals and automotive industries. Life science sectors such as pharmaceuticals, cosmetics, food and biotechnology are now using this strategy in various ways and with various degrees of porosity. Faced by ever-increasing demands for greater specialization and…[Read more]
Héloïse BRUNETON posted an update in the hub Last collaborations in R&D and Clinical (by Biowebspin) 7 hours, 43 minutes ago
07/2015: Congratulations to Illumina for its technical support in the study led by the Dr Yang. From Biowebspin News.
Héloïse BRUNETON posted an update in the hub Last collaborations in R&D and Clinical (by Biowebspin) 7 hours, 44 minutes ago
07/2015: Congratulation to Novo Nordisk for funding the study led by the Dr Andersson about Factor XIII Transglutaminase. From Biowebspin News.
Why Human Eggs Don’t Age Well
Source : asianscientist.com
Defective chromosome separation in the egg cells of older women can cause miscarriage and congenital diseases, scientists say.
Read the full article at http://www.asianscientist.com/2015/07/health/age-related-aneuploidy-oocyte-riken/
How enzymes manage their tasks | Biowebspin’s Blog
A new study, led by the Umeå University in Sweden, revealed a new aspect in enzymes that, in part, explains how enzymes manage their tasks with unmatched efficiency and selectivity.
The results of the study have been published in the journal Nature Communications.
So-called high-energy states in enzymes are regarded as necessary for catalysing…[Read more]
Understanding Heart Failure | Biowebspin’s Blog
One in five people will develop heart failure, a life threatening disease where the heart is unable to pump enough blood around the body. This video explains how heart failure impacts the body, and patients’ lives.
Read the full article at http://blog.biowebspin.com/understanding-heart-failure/
Week in Review: Zhongheng Pays $52 Million for Oramed's Diabetes Drugs
Source : chinabiotoday.com
Wuzhou Zhongheng paid $52 million for a 10% stake in Israel’s Oramed Pharma and China rights to its two oral diabetes treatments; Hadasit Bio Holdings, a medical transfer technology company located in Jerusalem, announced a $2 million investment from unspecified Chinese investors; Provectus Biopharma signed an LOI with…[Read more]
FDA accepts to review Pfizer's NDA for rheumatoid arthritis drug Xeljanz
Source : processandproduction.pharmaceutical-business-review.com
The US Food and Drug Administration (FDA) has accepted to review Pfizer’s new drug application (NDA) for Xeljanz (tofacitinib citrate) 11mg once daily modified release tablets to treat moderate to severe rheumatoid arthritis (RA) in patients who have had an inadequate response or…[Read more]
Natalya Kurochkina posted an update in the hub Protein Modeling at The School of Theoretical Modeling 1 day, 21 hours ago
Happy Forth of July!
Happy Independence Day!
Audiological Device Market : Global Industry Analysis,share,size and forecast 2014
2014 Global Audiological Device Industry Report is a professional and in-depth research report on the world’s major regional market conditions of the Audiological Device industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).
Pieter Achterberg posted an update 2 days, 5 hours ago
Wuzhou Zhongheng Invests $52 Million in Israel's Oramed Pharma
Source : chinabiotoday.com
Wuzhou Zhongheng Group paid $52 million for a 10% stake in Oramed Pharma and China rights to its two diabetes treatments. Oramed, based in Israel, develops oral versions of injected protein drugs. Details of the deal were not disclosed. In December 2014, Zhongheng invested $5 million in Oramed for a 7% stake in the…[Read more]
Biogen plans $1bn plant in Switzerland
Source : eurobiotechnews.eu
Biotech giant Biogen is investing CHF 1bn in a new pharmaceutical production plant in the Swiss town of Luterbach. Noted as one of the world’s oldest biotech firms, the new plant will create up to 400 jobs.
Read the full article at http://www.eurobiotechnews.eu/news/news/2015-03/biogen-plans-1bn-plant-in-switzerland.html
Benjamin Pfister posted an update in the hub Quality Assurance & Regulatory Affairs in pharmaceutical companies 2 days, 9 hours ago
Adaptimmune gets FDA acceptance for IND application for MAGE-A10 T in NSCLC patients
Source : regulatoryaffairs.pharmaceutical-business-review.com
The US Food and Drug Administration (FDA) has accepted UK-based biopharmaceutical firm Adaptimmune Therapeutics’ investigational new drug (IND) application for autologous genetically modified T-cells expressing enhanced T cell receptors (TCRs) specific for its therapeutic candidate…[Read more]
Teva launches generic Aggrenox capsules in US
Source : manufacturing.pharmaceutical-business-review.com
Teva Pharmaceutical Industries has launched generic Aggrenox (aspirin/extended-release dipyridamole) capsules in the United States.
Natalya Kurochkina posted an update in the hub Protein Modeling at The School of Theoretical Modeling 2 days, 16 hours ago
July Orientation Sessions
The School of Theoretical Modeling: Orientation sessions July 6, 10, 13, 17, 20, 24, 27, 31 2015 Register: http://www.schtm.org
Anurag Sharma posted an update 3 days, 2 hours ago
Gelatin Market Analysis, Segment, Trends and Forecasts, 2015: Acute Market Reports
2015 Global Gelatin Industry Report is a professional and in-depth research report on the world’s major regional market conditions of the Gelatin industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).
For further inquiries, about Gelatin Market – Global Industry…[Read more]
Héloïse BRUNETON posted an update in the hub Open Innovation and Technology Transfer Publications Feed 3 days, 3 hours ago
Evaluating Open Data Innovation: A Measurement Model for Digital Innovation Contests | Biowebspin
Digital innovation contests emerge as important intermediaries in open data markets. However the understanding of how contests affect innovation value chains is low and there is a lack of innovation measurement frameworks to support the management of digital innovation contests. Therefore, in this paper we apply design science to design a…[Read more]
Héloïse BRUNETON posted an update in the hub Last collaborations in R&D and Clinical (by Biowebspin) 3 days, 3 hours ago
06/2015: Congratulations to EpiVax for supporting the study led by the Dr Hirasawa about Leukocyte Antigen-DRB1*07:01. From Biowebspin News.
- Load More